Model for End-stage Liver Disease

被引:121
作者
Singal, Ashwani K. [1 ]
Kamath, Patrick S. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55902 USA
关键词
MELD; Liver transplantation; Cirrhosis;
D O I
10.1016/j.jceh.2012.11.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Model for end-stage liver disease (MELD) score, initially developed to predict survival following transjugular intrahepatic portosystemic shunt was subsequently found to be accurate predictor of mortality amongst patents with end-stage liver disease. Since 2002, MELD score using 3 objective variables (serum bilirubin, serum creatinine, and institutional normalized ratio) has been used worldwide for listing and transplanting patients with end-stage liver disease allowing transplanting sicker patients first irrespective of the wait time on the list. MELD score has also been shown to be accurate predictor of survival amongst patients with alcoholic hepatitis, following variceal hemorrhage, infections in cirrhosis, after surgery in patients with cirrhosis including liver resection, trauma, and hepatorenal syndrome (HRS). Although, MELD score is closest to the ideal score, there are some limitations including its inaccuracy in predicting survival in 15-20% cases. Over the last decade, many efforts have been made to further improve and refine MELD score. Until, a better score is developed, liver allocation would continue based on the currently used MELD score.
引用
收藏
页码:50 / 60
页数:11
相关论文
共 137 条
[1]   Cost of a Quality-Adjusted Life Year in Liver Transplantation: The Influence of the Indication and the Model for End-Stage Liver Disease Score [J].
Aberg, Fredrik ;
Maklin, Suvi ;
Rasanen, Pirjo ;
Roine, Risto P. ;
Sintonen, Harri ;
Koivusalo, Anna-Maria ;
Hockerstedt, Krister ;
Isoniemi, Helena .
LIVER TRANSPLANTATION, 2011, 17 (11) :1333-1343
[2]   Differences in access to liver transplantation: Disease severity, waiting time, and transplantation center volume [J].
Ahmad, Jawad ;
Bryce, Cindy L. ;
Cacciarelli, Thomas ;
Roberts, Mark S. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (10) :707-713
[3]   Model for End-Stage Liver Disease Predicts Mortality for Tricuspid Valve Surgery [J].
Ailawadi, Gorav ;
LaPar, Damien J. ;
Swenson, Brian R. ;
Siefert, Suzanne A. ;
Lau, Christine ;
Kern, John A. ;
Peeler, Benjamin B. ;
Littlewood, Keith E. ;
Kron, Irving L. .
ANNALS OF THORACIC SURGERY, 2009, 87 (05) :1460-1468
[4]   MELD score and clinical type predict prognosis in hepatorenal syndrome:: Relevance to liver transplantation [J].
Alessandria, C ;
Ozdogan, O ;
Guevara, M ;
Restuccia, T ;
Jiménez, W ;
Arroyo, V ;
Rodés, J ;
Ginès, P .
HEPATOLOGY, 2005, 41 (06) :1282-1289
[5]   MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices [J].
Amitrano, L ;
Guardascione, MA ;
Bennato, R ;
Manguso, F ;
Balzano, A .
JOURNAL OF HEPATOLOGY, 2005, 42 (06) :820-825
[6]   Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score [J].
Angermayr, B. ;
Luca, A. ;
Konig, F. ;
Bertolini, G. ;
Ploner, M. ;
Gridelli, B. ;
Ulbrich, G. ;
Reiberger, T. ;
Bosch, J. ;
Peck-Radosavljevic, M. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (01) :65-71
[7]   The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice [J].
Antaki, Fadi ;
Lukowski, Anna .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (04) :412-415
[8]  
Argo C K, 2011, Am J Transplant, V11, P2353, DOI 10.1111/j.1600-6143.2011.03738.x
[9]   Model for End-Stage Liver Disease: End of the First Decade [J].
Asrani, Sumeet K. ;
Kim, W. Ray .
CLINICS IN LIVER DISEASE, 2011, 15 (04) :685-+
[10]   The Cost and Quality Paradox [J].
Axelrod, D. A. ;
Lentine, K. L. ;
Salvalaggio, P. R. ;
Schnitzler, M. A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) :985-986